SOX2 and cancer: RT-PCR analysis showed significantly (p<0.01) higher expression of prominent stem cell factors—SOX2, OCT4, and NANOG—in CD133+EpCAM+ cells (43–45) compared to their negative fractions, corroborating their characterization as cancer stem-like cells (Figure 3B).